Evidence map›Paper›PMID 40208055›Full record

ArticleInfection and immunity2025

Involvement of CD146 in the

Wei Liu, Junhong Chen, Ting Wang, Ying Gong, Chen Yang, Yuwei Li, Xiyun Yan, Hongxia Duan, Xiaoming Wang, Mingshun Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wei LiuDepartment of Immunology, National Vaccine Innovation Platform, NHC Key Laboratory of Antibody Technique, Jiangsu Key Laboratory of Pathogen Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu, China.
Junhong ChenDepartment of Immunology, National Vaccine Innovation Platform, NHC Key Laboratory of Antibody Technique, Jiangsu Key Laboratory of Pathogen Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu, China.
Ting WangDepartment of Immunology, National Vaccine Innovation Platform, NHC Key Laboratory of Antibody Technique, Jiangsu Key Laboratory of Pathogen Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu, China.
Ying GongDepartment of Immunology, National Vaccine Innovation Platform, NHC Key Laboratory of Antibody Technique, Jiangsu Key Laboratory of Pathogen Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu, China.
Chen YangDepartment of Immunology, National Vaccine Innovation Platform, NHC Key Laboratory of Antibody Technique, Jiangsu Key Laboratory of Pathogen Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu, China.
Yuwei LiDepartment of Immunology, National Vaccine Innovation Platform, NHC Key Laboratory of Antibody Technique, Jiangsu Key Laboratory of Pathogen Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu, China.
Xiyun YanNanozyme Laboratory in Zhongyuan, Henan Academy of Innovations in Medical Science, Zhengzhou, Henan, China.
Hongxia DuanNanozyme Laboratory in Zhongyuan, Henan Academy of Innovations in Medical Science, Zhengzhou, Henan, China.ORCID 0000-0003-3995-1228
Xiaoming WangDepartment of Immunology, National Vaccine Innovation Platform, NHC Key Laboratory of Antibody Technique, Jiangsu Key Laboratory of Pathogen Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu, China.ORCID 0000-0003-0679-9768
Mingshun ZhangDepartment of Immunology, National Vaccine Innovation Platform, NHC Key Laboratory of Antibody Technique, Jiangsu Key Laboratory of Pathogen Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu, China.ORCID 0000-0001-5925-0168

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cryptococcal meningitis is a common and refractory central nervous system (CNS) infection with high mortality and disability. For

Indexed as

BrainCD146 AntigenCryptococcosisCryptococcus neoformansEndothelial CellsAnimalsBlood-Brain BarrierCell AdhesionHumansMiceMice, Inbred C57BLCD146 Antigenblood-brain barrierCD146Cryptococcus neoformansendothelial cellsneutralization

Identifiers

PMID40208055
PMCPMC12070736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.